Boston Scientific Corp. (BSX)

Cash Flow Statement
Quarterly Data

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Boston Scientific Corp., consolidated cash flow statement (quarterly data)

US$ in millions

	3 months ended	Sep 30, 2019		Jun 30, 2019		Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Cash provided by (used for) operating activities
	Purchases of property, plant and equipment
	Proceeds from sale of property, plant and equipment
	Payments for acquisitions of businesses, net of cash acquired
	Payments for investments and acquisitions of certain technologies
	Proceeds from divestiture of certain businesses
	Payments for settlements of hedge contracts
	Proceeds from investments and collections of notes receivable
	Cash used for investing activities
	Payment of contingent consideration amounts and royalty rights previously established in purchase accounting
	Payments on short-term borrowings
	Proceeds from short-term borrowings, net of debt issuance costs
	Net increase (decrease) in commercial paper
	Payments on borrowings from credit facilities
	Proceeds from borrowings on credit facilities
	Payments on long-term borrowings and debt extinguishment costs
	Proceeds from long-term borrowings, net of debt issuance costs
	Payments for acquisitions of treasury stock
	Cash used to net share settle employee equity awards
	Proceeds from issuances of shares of common stock
	Cash provided by (used for) financing activities
	Effect of foreign exchange rates on cash
	Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents

Cash flow statement item	Description	The company
Cash provided by (used for) operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Boston Scientific Corp.’s cash provided by (used for) operating activities decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 exceeding Q1 2019 level.
Cash used for investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Boston Scientific Corp.’s cash used for investing activities decreased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Cash provided by (used for) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Boston Scientific Corp.’s cash provided by (used for) financing activities decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 not reaching Q1 2019 level.

	Boston Scientific Corp.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

Boston Scientific Corp. (BSX)

Cash Flow StatementQuarterly Data

Cash Flow Statement
Quarterly Data